Abstract Approximately one-third of patients with epilepsy continue to have seizures despite antiepileptic therapy. Many seizures occur in diurnal, sleep/wake, circadian, or even monthly patterns. The relationship between biomarkers and state changes is still being investigated, but early results suggest that some of these patterns may be related to endogenous circadian patterns whereas others may be related to wakefulness and sleep or both. Chronotherapy, the application of treatment at times of greatest seizure susceptibility, is a technique that may optimize seizure control in selected patients. It may be used in the form of differential dosing, as preparations designed to deliver sustained or pulsatile drug delivery or in the form of 'zeitgebers' that shift endogenous rhythms. Early trials in epilepsy suggest that chronopharmacology may provide improved seizure control compared with conventional treatment in some patients. The present article reviews chronopharmacology in the treatment of epilepsy as well as future treatment avenues.
Introduction
Epilepsy affects nearly 1 % of the population. In spite of the development of a greater number of medications over the last decade, nearly one-third of epilepsy patients continue to have seizures despite available pharmacological approaches [1] . Only some patients qualify for epilepsy surgery [2] or may be treated with VNS, deep brain stimulation, or ketogenic diets [3, 4] . Therefore, there is an urgent medical need to improve epilepsy management to provide improved seizure control. A therapeutic intervention that consists of treatment timing at times of greatest seizure susceptibility may help some patients that do not respond to conventional pharmacotherapy. Additional evidence on seizure patterns throughout day and night is becoming available, and a relationship between seizure timing and the localization and semiology of seizures has been suggested [5•, 6, 7•] . With the aid of seizure prediction models and the identification of periods of greater seizure risk, additional strategies may be developed to provide improved seizure control at times when seizures are most likely. Few studies have evaluated chronotherapy in the treatment of epilepsy [8••, 9 ••]. We provide an overview of chronotherapy, diurnal and nocturnal patterns of seizure clustering, and preliminary applications demonstrating the use of chronotherapy in the treatment of epilepsy.
Ways to Assess Timing and Biological Rhythms
While 24-hour clock times and sleep/wake rhythms frequently overlap with the internal clock, they do not always match the circadian rhythm. There are a variety of methods to ascertain the timing of biological clocks. Melatonin provides the most reliable and consistent measure of the circadian pattern and can be measured in the plasma, saliva, or urine [10] . Because secretion of the hormone is acutely suppressed by light exposure, the measurement of the time of onset of the daily melatonin rise during low-light exposure is a more reliable measure of the circadian phase [10, 11] . The dim-light melatonin onset (DLMO) has been used to assess alterations of circadian phase in a variety of diseases [12] [13] [14] , and has also been trialed in epilepsy [15] . Other markers, such as core body temperature, and cortisol may also serve as biomarkers for circadian rhythms. Cortisol can be measured in serum and saliva. Cortisol typically rises in the late evening and early morning. Another marker, core body temperature usually falls during nighttime and rises during the morning to afternoon [10] . Body temperature can be measured through wrist and rectal measurements, though corrections are needed to account for different activities and climates [16] . Due to overlap of circadian rhythms and sleep cycle, forced separation of both can also serve as a tool to assess the effect of sleep and of the circadian rhythm separately. For that purpose, forced desynchrony paradigms separating sleep/wake cycle and circadian rhythms have been designed [17] .
Chronotherapeutics

Aligning Therapy to Endogenous Rhythms
Chronopharmacology refers the "design and evaluation of drug delivery systems that release a bioactive agent at a rhythm that ideally matches the biological requirement of a given disease therapy" [18] . Chronotherapy can be delivered through a variety of strategies and may include both time and site-specific drug application regimens. Differential dosing strategies, for example, may rely on distributing the dosage of the drug to correspond with periods of maximal disease severity (Fig. 1) . Other strategies may employ drug delivery systems which allow, depending on the need, for sustained or pulsatile release of drug at the location in the body where it is needed most. Zero-order release systems ensure that a constant amount of drug is transferred into the plasma over time. Similar systems and devices may be implemented in epilepsy care utilizing osmotically driven pumps and controllable swelling matrices [19•] . These systems can ensure a constant plasma level of drug. Pulsatile drug delivery systems, in which the plasma level of drug fluctuates in a periodic manner, have been formulated using microparticles, coarse particles, solid implants, hydrogels, osmotic pumps, and liposomes [19•] . Through the use of these strategies, the timing of drug availability may be optimized for a given disease with symptoms that follow a periodic pattern.
Biological Basis of Chronotherapeutics
Chronopharmacological techniques ensure that drug levels in the blood are within therapeutic ranges during periods of maximal disease severity. An example of this is seen in how evening doses of antihypertensive therapy can be used to prevent morning rises in blood pressure [20] . The evening dose of the drug may thus be well timed with diurnal changes in blood pressure, preventing diurnal worsening of hypertension.
Receptor changes and receptor holidays experienced during trough periods of drug activity may decrease tolerance to antiepileptic medications, thereby improving their efficacy during periods of greater need. The sensitivity of rats with experimental Parkinson's disease exposed to dopaminergic drugs, for example, can be temporarily enhanced following short term treatment withdrawal [21] . In addition, medications may have a different effect based on the timing of the dose. The efficacy of ketamine, for example, has been shown to have varying efficacy based on the timing of dose despite reaching equivalent plasma concentrations, giving rise to the theory that some of these diurnal effects may be due to changes in receptors or secondary messenger systems [22] . Chronotherapy may prevent up-or down-regulation of receptors during periods of lesser need allowing optimal efficacy during periods of disease exacerbation.
Chronotherapy in Chronic Medical Conditions
Chronotherapy has shown promise in a number of diseases. Asthma, for example, can be managed through timed dosing to provide superior symptom control [23] . The finding that bedtime blood pressure serves as an independent risk factor for cardiovascular events in diabetics has prompted interest in time-locked therapies to specifically reduce blood pressure during these hours [24] . Targeted treatments towards circadian rhythms may play an important role in the treatment of obesity [25] . Chronotherapy may be also useful in formulating treatments for conditions such as tumors [26] , arrhythmias [27] , ischemic heart disease [28] , psychiatric disease [29] , HIV [30] , diabetes [31] , and other chronic medical conditions.
Seizure Patterns in Epilepsy
Early observations of relationships by Gowers linking sleep/ wake and diurnal patterns in epilepsy can be dated to the late 1800s [32] . Additional patterns in epilepsy have been elucidated over the last few decades (Table 1) . Some of these patterns have been identified in relation to the 24-hour clock, the sleep/wake cycle, and the circadian rhythm. Beyond these, other cycles may also be involved, including catamenial seizures. Other factors that may account for seizure patterns over larger timeframes may involve seasonal variations in climate [33, 34] and infections [35] . Epilepsy may therefore be an excellent candidate for chronopharmacological treatment approaches due to suspected associations of seizure exacerbation with some of these biological rhythms and triggers.
Diurnal Patterns of Seizures
Many seizures follow a diurnal pattern and these patterns are influenced by factors including EEG localization, seizure semiology, etiology, and age.
EEG Localization
The most consistent seizure pattern descriptions are related to ictal EEG localization. Temporal lobe seizures have been documented to occur more in the afternoon [5•, 36, 38] and may also have an additional morning peak [5•, 6] . Frontal lobe seizures occur more in the early morning [5•, 6] . Data for occipital lobe and parietal lobe seizures are based on fewer reported patients, but occipital lobe seizures may occur more in the afternoon and parietal seizures may occur more in the morning [5•, 6] . Generalized seizures are documented to occur most frequently in the early morning [6, 39•] .
Semiology
Fewer studies have investigated seizure patterns based on their semiological manifestations. However, diurnal patterns have been identified for tonic, clonic, tonicclonic, automotor, hypermotor, atonic, myoclonic, hypomotor, and dyscognitive seizures and epileptic spasms [6, 36, 40] . Secondary generalized seizures have been noted to occur more frequently at night [41] . Clinical seizure evolutions may serve as an additional factor in predicting seizure occurrence [42] .
Age may affect timing of seizures, as demonstrated in a study analyzing diurnal patterns of epileptic spasms in different age groups [40] and a study on secondary generalizations [41] .
Sleep/Wake Patterns of Seizures
A comparison between sleep/wake and 24-hour timing of seizures found sleep/wake status to be more predictive of seizure occurrence [6] . Sleep/wake patterns have been studied in respect to EEG localization, and seizure semiology. Other factors may play a role as well. One study, for example, noted that patients with Taylor type focal cortical dysplasia were more likely to have seizures out of sleep [43] .
EEG Localization
Temporal lobe epilepsy occurs more during wakefulness, as established in a variety of adult and pediatric studies [6, 44] . Generalized seizures classically occur soon after arousal [39•] . Occipital and parietal lobe seizures may also occur more out of wakefulness [45] , and frontal lobe seizures occur more during sleep [44] . Nobili et al, 2009 [43] Retrospective 313 patients seizure free after resective surgery for drug-resistant focal epilepsy 1. Higher frequency of sleep related epilepsy (SRE) associated with a frontal lobe EZ and Taylor's FCD, whereas architectural FCD, ganglioglioma, and MTS were correlated with a reduced frequency of SRE.
2. Variable associated with SRE: presence of a TFCD -increased 14-fold the risk of SRE.
Karafin et al, 2010 [38] Retrospective 60 patients -mTLE seizure-free after anterior temporal lobectomy (mean of 10 seizures) 1. Two modes: 7 AM-8 AM and 4 PM-5 PM.
2. Seizure frequency: at 6 AM-8 AM and 3 PM-5 PM.
Loddenkemper et al, 2011 [6] Retrospective 225 children 1. Generalized and temporal seizures more during wakefulness. 2. Frontal and parietal seizures more during sleep. Ramgopal et al, 2012 [41] Retrospective 71 Children and adolescents with generalized tonic clonic evolution 1. Tonic-clonic evolution: midnight-3 AM and 6 AM-9 AM.
2. Generalized EEG onset: more tonic-clonic evolution between 9:00-12 PM.
Yildiz et al, 2012 [110] Retrospective 68 patients -FLE and TLE Duration between awakening and seizure onset. 
Seizure Semiology
Auras, hypomotor, atonic, dyscognitive seizures and epileptic spasms occur significantly more frequently during wakefulness. Tonic, automotor, and hypermotor seizures occur more during sleep [6] . Secondary generalized seizures occur more out of sleep, demonstrated in both pediatric [41] and adult [45, 46] studies.
Circadian Patterns of Seizures
A pilot study investigated associations between DLMO and the occurrence of seizures in patients with temporal and frontal lobe epilepsy undergoing video-EEG [15] . These authors found that temporal lobe seizures occurred most frequently 6 hours before the melatonin onset and frontal lobe seizures occurred most frequently 6-12 hours after this time. More research is needed to definitively associate the circadian rhythm to the occurrence of epileptic seizures.
Catamenial Patterns in Seizures
The exact patterns of catamenial seizures vary. In a study of 184 women with epilepsy, seizures clustered around the menstrual cycle in 3 patterns: a peri-menstrual pattern, an ovulatory phase pattern, and a luteal phase pattern [47] . These patterns may relate to imbalances between proconvulsant estrogen and anticonvulsant progesterone, or may occur secondary to alterations in water balance or antiepileptic drug metabolism [48] . Treating seizures with higher epilepsy medication doses at times of greatest seizure susceptibility may relieve seizure burden.
Lunar Patterns in Seizures
Changes in lunar phases have long been believed to be associated with the timing of seizures. In a study investigating the timing of seizures in respect to the moon phase using patient data from an epilepsy monitoring unit, a negative correlation was identified between seizures and the fraction of the moon illuminated by the sun. Because these findings disappeared following correction of the clarity of the night, this study suggested that nocturnal light during full moon phases may decrease the frequency of seizures during these times [49] .
Seizure Patterns in Epilepsy Syndromes
Certain epilepsy syndromes may manifest with different seizure patterns. Seizures in juvenile myoclonic epilepsy most frequently occur during the transition from sleep to wakefulness [50] . Studies of seizure patterns in West Syndrome found that seizures occurred more frequently during the morning hours [51] . The characteristic occurrence of early morning idiopathic generalized tonic clonic seizures in some patients is considered as a distinct syndrome [52] .
Patients with specific epilepsy syndromes may have more complex seizure cluster patterns that may open an additional therapeutic window.
Epilepsy Modifies the Circadian Rhythm and Sleep
The relationship between epilepsy and the circadian rhythm is most likely bidirectional. Melatonin levels are on average lower in patients with epilepsy compared with controls [53] , and additionally, patients with epilepsy may have stronger fluctuations between the day and nighttime levels of the hormone [54] . Patients with epilepsy are known to have a wide variety of changes in sleep architecture [55•] . These include macrostructural sleep abnormalities, including increased number of awakenings, reduced sleep efficiency, sleep fragmentation, and abnormal K-complexes. Some of these changes may in turn lead to worsening of seizures [56] .
Sleep Deprivation and Epilepsy
There are strong associations between sleep deprivation and seizures. Sleep deprivation is well known, for example, to aggravate seizures in patients with juvenile myoclonic epilepsy and it may also play a role in other forms of epilepsy and related interictal epileptiform discharges. In a retrospective study evaluating the presence of epileptiform discharges among patients undergoing sleep deprivation, 52 % of patients presented with spike activation on EEG following sleep deprivation [57] . Sleep deprivation may also play an important role in patients whose seizures disrupt sleep. Sleep deprivation and modifications of sleep schedules may be used in selected patients in the epilepsy monitoring unit during presurgical workup to be able to inject seizures with radioactive tracer during presurgical ictal Single Photon Emission Computed Tomography (SPECT) evaluations.
Chronopharmacokinetics of Epilepsy Medications
Overview of Chronopharmacokinetics in Epilepsy
Endogenous cycles can affect all aspects of the pharmacodynamics and pharmacokinetics of antiepileptic medications. A variety of parameters, including the peak drug plasma concentration (C max ), time to reach maximum concentration (t max ), area under the concentration-time curve (AUC), volume of distribution (Vd), protein binding, elimination half-life (t 1/2 ), and clearance (CL) can be affected by the timing and delivery of drugs. Rational chronotherapeutic strategies require a thorough understanding of how drug pharmacokinetics are affected by their timing and delivery. Chronopharmacokinetics is the study of changes in the absorption, metabolism, distribution, and elimination of drugs in the body. Absorption may be altered based on dietary cues and circadian gene expression: lipophilic drugs, for example, are absorbed faster in the morning compared with later in the day [58] . Distribution may be affected by cyclic rates of blood flow to various organs and capillary blood flow. Furthermore, free plasma levels of drugs show rhythmic changes [58] . The elimination of drugs can be altered by variations in the rates of metabolism and excretion of drugs over time [58, 59] . The use of specialized formulations, such as galenic drug delivery systems, may alter the digestion and rate of absorption of drugs [58, 60] and are an important consideration in formulating a workable chronotherapeutic strategy.
Animal Studies
Some of the earliest data suggesting an effect of circadian and other cycles affecting the pharmacokinetics of antiepileptic drugs (AEDs) were obtained from animal studies. A variety of components involved in the absorption, distribution, metabolism, and excretion of drugs are likely affected by endogenous rhythms. Variations in plasma protein levels may alter AED availability. Free levels of carbamazepine administered in rodents, for example, are nearly twice as high around noon as compared with the morning. These changes are noted to be inversely proportional to diurnal changes in albumin concentration. Varying protein levels may therefore alter the availability of bioactive drug throughout the day [61] .
Changes in plasma levels of drugs may also relate to patterns of drug excretion. In a study evaluating mice continuously infused with valproate via mini-pumps, drug levels were noted to be highest during light exposure. Clearance of drug was greatest during dark exposure [62] . Changes in pharmacokinetic parameters may therefore occur irrespective of the timing of drug administration due to differential excretion of the drug.
Human Studies
Digestion and Absorption
The timing of medication in respect to meals plays an important role in the absorption of AEDs. The absorption of valproate, for example, can be delayed for hours if taken after a meal [63] . Consumption of breakfast prior to intake of carbamazepine is noted to delay the absorption of delayed-release forms of the drug disproportionately compared with the standard form [64] . The quantity of food taken at meals may play a role as well. Subjects who take a light breakfast and heavy dinner are more likely to have a higher maximal plasma or serum concentration (C max ), shorter time after administration needed to achieve maximal plasma or serum level (t max ), and a larger absorption rate (Ka) following morning dose of valproate compared with those who take a light breakfast and light dinner [65] .
Distribution
The distribution of medications is also affected by cyclic changes. Binding to plasma proteins plays an important role in the distribution of valproate: maximal free concentrations of the drug occur between 2-6 AM. In contrast, valproate is most likely to be bound to proteins during the afternoon [66] . Variations in red blood cell concentrations may modify the distribution of valproate, 20 % of which is conveyed in erythrocytes [67, 68] . In patients taking morning and evening doses of valproate, the drug achieves higher serum concentrations and decreased t max following the morning dose, in comparison to the evening dose [69] .
The distributions of other AEDs likely vary as well in relation to circadian and diurnal rhythms. Mild day/night fluctuations have been observed in patients on continuous infusion of midazolam [70] . In a study with 28 healthy volunteers comparing the pharmacokinetics of diazepam, subjects who took the medication orally demonstrated a more rapid C max and shorter T max following the morning dose compared with the evening dose. These changes may be accounted for by changes in the absorption and distribution of the medication [71] . Another study noted that plasma levels of carbamazepine and related metabolites were higher 24 hours post-dose during the night compared with the day, a finding which may be due to changes in plasma distribution and protein binding [72] . To date, no other studies have investigated similar changes with other AEDs.
Metabolism
Selective enzyme expression in the liver may impact the metabolism of drugs. Clock genes in mammalian hepatic cells are largely induced by feeding cycles rather than the suprachiasmatic nucleus [73] . Circadian patterns have been observed in murine glutathione-S-transferase, an enzyme needed for drug conjugation [74, 75] . The CYP3A4 gene, required for digestion of carbamazepine, may be expressed in a diurnal fashion, as demonstrated in an in vitro study [76] . Beta oxidation has also shown diurnal changes in activity [77] , and the effect of Beta oxidation on anticonvulsant therapy still under investigation.
Excretion
Circadian oscillations in renal function may cause changes in glomerular filtration [78] and may impact the excretion of certain electrolytes [79, 80] . Some of these changes may impact the manner in which the kidney excretes medications or metabolites. The excretion of 3-oxo-VPA and VPA glucuronides, metabolites of valproic acid, has been observed to be least between 2-8 AM, a factor that could not be accounted to differences in creatinine excretion [81] . This finding suggests that the excretion of some drugs may be affected by diurnal or circadian patterns.
Other Factors
Behavioral factors may also play an important role in the timing of dosage of AEDs. People who woke up earlier on free days, or "morning types," tended to take their medications earlier in the day compared with those who woke up later [82•] . Beyond the pharmacokinetic modeling of individual medications, these factors must also be considered when formulating chronotherapeutic treatment strategies.
Chronopharmacodynamics of Epilepsy Medications
AEDs can also modify circadian, diurnal, or wake/sleep patterns. AEDs may have varying toxicity or efficacy depending on the timing of their administration. These in turn may change the efficacy or duration of AEDs or of intrinsic seizure activity. A number of human and animal studies have explored chronopharmacokinetic aspects of antiepileptic drugs (Table 2) .
Animal Studies
Effect of Benzodiazepines on Gene Transcription
Medications may alter the transcription and activity of circadian-related genes. Diazepam was noted to alter the phase of the circadian clock by increasing or decreasing the expression of clock genes in adult and embryonic zebrafish [83] . This finding may possibly extend to other benzodiazepines.
Timing of Drug Administration and Toxicity of Valproate
A study investigating such effects in mice entrained by a strict 12-hour light cycle evaluated the toxicity of valproate given at certain times found that mortality was highest when administered at 5 PM and least when administered at 9 PM and 1 PM. These findings, which were noted despite a lack of difference in cerebrospinal fluid and plasma concentrations of the drug, suggest that the toxic effects of valproate may be related to the underlying sensitivity of the CNS to the drug at different periods of the day [84] . A murine study found that the valproate was most toxic when administered 17 hours after light onset. Least toxicity occurred when it was administrated 9 hours after light onset, which corresponds to the second half of the night in humans [85•] .
Embryotoxicity of AEDs may be Related to Drug Timing
Teratogenic effects of medications to the fetus may have variations depending on the timing of administration. In a study evaluating effects of valproate given to pregnant mice, the highest fetal mortality occurred when the drug was injected at 5 PM. Lower mortality occurred when given at 1 AM. These findings may carry important implications in limiting the toxicity of AEDs in women of childbearing age [86] .
Human Studies
Valproate
Valproate was found to decrease the sensitivity of melatonin secretion to light in patients treated with a single dose for bipolar disorder. This did not have an effect on overall melatonin secretion or the dim-light melatonin onset time [87] . A study evaluating the circadian effects of valproate on Drosophilia found that the drug lengthened the period of the circadian rhythm and promoted rhythmicity [88] . Real-time PCR analysis on mice and human fibroblasts has shown that the valproate can advance or delay the rhythmic expression of the circadian gene Period2::Luciferace depending on the time of administration [89] .
Other Medications
Diazepam may delay the secretion of melatonin, and, according to the above mentioned studies, alter the transcription of circadian genes. Disturbance of sleep architecture has been investigated in carbamazepine, levetiracetam, lamotrigine, vigabatrin and gabapentin [90] [91] [92] . It is unclear if and to what extent these drugs modify the sleep/wake cycle or circadian rhythm.
Trials of Chronopharmacotherapy in Epilepsy
To date, few studies have attempted to utilize principles of chronopharmacology in differential dosing trials. As described above, a number of animal studies have also investigated chronopharmacological aspects of drug toxicity.
Timed Dosing in Patients with Carbamazepine and Phenytoin
Yegnanarayan and colleagues tested the efficacy of differential dosing of carbamazepine and phenytoin in epilepsy patients [9••] . The investigators evaluated 52 patients in 3. AUC is similar for both preparations.
Yoshiyama et al, 1989 [69] 8 healthy volunteers
Chronopharmacokinetics of oral and rectal VPA 1. Oral administration: absorption greater in the morning compared with evening.
Morning dose had higher Cmax, shorter t max , and larger Ka compared with evening.
2. Rectal administration: no significant difference in VPA kinetics between morning and evening trials.
Ohdo et al, 1992 [65] 16 healthy volunteers VPA pharmacokinetics in meals VPA regimen in patients taking light breakfast and heavy dinner has higher Cmax, shorter t max , and larger Ka following morning dose compared with VPA regimen in patients taking standard portions of breakfast and dinner.
Petker Degen et al, 1994 [112] 6 healthy volunteers Effect of food on pharmacokinetics of OXC 1. AUC: increased by 16 % and Cmax increased by 23 % when OXC was given with food.
2. t max and terminal half-life of OXC were not influenced by concomitant intake of food. 3. OXC tolerated equally well when taken with or without food.
Olano et al, 1998 [72] 6 healthy volunteers
Pharmacokinetics of CBZ and CBZ metabolite (carbamazepine-10, 11 epoxide) After 24 h post-dose, CBZ and CBZ metabolite concentration in plasma and saliva were greater during the night.
Animal studies Ohdo et al, 1989 [84] Mice Acute toxicity of VPA 1. Acute toxicity: highest mortality when injected at 5 PM and lowest at 9 AM or 1 AM. 2. Time course of mean plasma and brain VPA concentrations after an injection of VPA was similar in mice injected at 5 PM and mice injected at 1 AM.
whom the total dose of medication was kept constant but in whom the majority of the dose was given at 8 PM. The study found that subjects in the trial group were more likely to reach therapeutic drug levels following 4 weeks of therapy compared with controls. Controls were treated with twice-or once-daily regimens. More patients in the study group attained better seizure control compared with controls.
The investigators focused their study on patients found to have subtherapeutic drug levels on monitoring, and did not study patients specifically in whom seizures followed a specific diurnal pattern. The findings of the study are suggestive of the ability of differential dosing to limit the emergence of drug troughs.
Nocturnal Medication Dosing
A more targeted approach towards differential dosing was attempted in a pilot trail, published by Guilhoto et al. Eighteen patients with nocturnal or early-morning seizures refractory to conventional AED therapy were prospectively enrolled in a differential dosing trial. Patients were treated with a schedule in which the evening dose was twice the morning dose, keeping the total dose of medication constant. Of the 18 patients treated by this dosing strategy, 11 patients became seizure-free following a mean follow up time of 5.3 months, and 4 patients had a 75 %-90 % reduction of seizures. This study suggested that chronotherapy can provide improved seizure control compared with conventional therapy in carefully selected patients [8••] .
Limiting Toxic Effects of Antiepileptic Drugs
Chronopharmacology may provide avenues towards limiting the adverse effects of antiepileptic medications. As a part of one chronotherapy trial, Yegnanarayan evaluated the tolerance the adverse effects of patients treated on a chronotherapeutic schedule. While symptoms of toxicity were present in both groups, symptoms of toxicity subsided more rapidly in patients treated with differential dosing [9••] . In the pilot study conducted by Guilhoto, 2/18 subjects complained of fatigue [8••] .
Other Avenues of Chronotherapy in Epilepsy
Melatonin
Melatonin has been noted to rise following seizures. This change has contributed to reports that indicate a potential anticonvulsant effect of melatonin [93] . Melatonin has been postulated to suppress seizure activity at certain doses. Potential explanations for this effect include antioxidant activity [94] or GABA-potentiating effects [95] . A recent review of the literature noted that published trials of melatonin therapy were limited and delivered conflicting results [96] . More research will be needed in order to evaluate the efficacy of melatonin for epilepsy. However, melatonin is also used as chronotherapeutic medication to adjust the circadian rhythm, and may therefore have a role in the alignment of the circadian rhythm [97] . . The use of localized medications may also be a useful way to abort or minimize seizure activity. In murine experiments, intra-hippocampal adenosine was shown to reduce seizure frequency [102] . Continuous intra-amygdala and intra-thalamic infusion of gamma amino butyric acid has been similarly shown to reduce kindling [103] . Closed loop methods utilizing these types of local drug delivery systems may serve as useful techniques for seizure abortion. These localized delivery systems in combination with individual timing of medication according to patterns of seizures may allow for highly targeted and specific therapy in line with endogenous rhythms (Fig. 1 ).
Conclusions
Chronotherapy carries potential to better control seizures and limit adverse effects. More data are needed to study the manner in which endogenous rhythms alter the digestion, absorption, distribution, metabolism and excretion of AEDs.
In addition, antiepileptic drugs may themselves cause changes in circadian patterns in ways that are currently poorly understood. Pharmacokinetic and phamacodynamic profiles of individual medications need to be clearly elucidated. Chronotherapy has important clinical implications for epilepsy management. Patients are encouraged to track the timing of their seizures, potentially using electronic seizure detection devices. Seizure diaries may be especially useful for this purpose, and some electronic diaries now also provide a breakdown of seizure timing and thereby assist in medication management. We are currently working on algorithms that can automatically implement this clinical information in outcome prediction and treatment algorithms and these electronic aids may therefore help clinicians with treatment choices in the future. Furthermore, differential dosing strategies or temporary treatment with intermittent antiepileptic medication therapy may be feasible in patients with well-defined seizure clusters. Clinicians should be aware that this approach has not yet been thoroughly studied and that complications including increased toxicity and breakthrough seizures may occur. While these caveats should be considered, the clinical applications of chronopharmacology may lead to improved seizure control in some patients.
In order for chronotherapy to have a firm footing in clinical practice, more data are needed to evaluate which patients may benefit from chronotherapy. Further study is also needed to formulate dosing strategies based on patientspecific seizure patterns. Future study should be based on retrospective reviews, bimarker studies, and surveys. Additionally, randomized controlled trials should be performed in the next few years. In addition to treatment with traditional AEDs, novel avenues of chronotherapy include melatonin and light therapy. While more data are needed, the available evidence suggests that chronotherapy may play an important role in providing better control of seizures. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
